WO1998006747A3 - Uses for wnt polypeptides - Google Patents
Uses for wnt polypeptides Download PDFInfo
- Publication number
- WO1998006747A3 WO1998006747A3 PCT/US1997/013910 US9713910W WO9806747A3 WO 1998006747 A3 WO1998006747 A3 WO 1998006747A3 US 9713910 W US9713910 W US 9713910W WO 9806747 A3 WO9806747 A3 WO 9806747A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wnt polypeptides
- wnt
- polypeptides
- hematopoiesis
- differentiation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12812997A IL128129A0 (en) | 1996-08-16 | 1997-08-07 | Uses of wnt polypeptides |
AU39112/97A AU721947B2 (en) | 1996-08-16 | 1997-08-07 | Uses for WNT polypeptides |
AT97936448T ATE252113T1 (en) | 1996-08-16 | 1997-08-07 | USE OF WNT POLYPEPTIDES |
EP97936448A EP0918794B1 (en) | 1996-08-16 | 1997-08-07 | Uses for wnt polypeptides |
DE69725587T DE69725587T2 (en) | 1996-08-16 | 1997-08-07 | USE OF WNT POLYPEPTIDES |
JP50986198A JP3759623B2 (en) | 1996-08-16 | 1997-08-07 | Use with Wnt polypeptides |
CA002262469A CA2262469C (en) | 1996-08-16 | 1997-08-07 | Uses for wnt polypeptides |
IL128129A IL128129A (en) | 1996-08-16 | 1999-01-19 | Uses for human wnt polypeptides |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/696,566 US5851984A (en) | 1996-08-16 | 1996-08-16 | Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides |
US08/696,566 | 1996-08-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998006747A2 WO1998006747A2 (en) | 1998-02-19 |
WO1998006747A3 true WO1998006747A3 (en) | 1998-05-07 |
Family
ID=24797608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/013910 WO1998006747A2 (en) | 1996-08-16 | 1997-08-07 | Uses for wnt polypeptides |
Country Status (9)
Country | Link |
---|---|
US (1) | US5851984A (en) |
EP (1) | EP0918794B1 (en) |
JP (1) | JP3759623B2 (en) |
AT (1) | ATE252113T1 (en) |
AU (1) | AU721947B2 (en) |
DE (1) | DE69725587T2 (en) |
ES (1) | ES2208943T3 (en) |
IL (2) | IL128129A0 (en) |
WO (1) | WO1998006747A2 (en) |
Families Citing this family (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6159462A (en) * | 1996-08-16 | 2000-12-12 | Genentech, Inc. | Uses of Wnt polypeptides |
AU770896C (en) | 1998-09-29 | 2006-09-07 | Gamida Cell Ltd. | Methods of controlling proliferation and differentiation of stem and progenitor cells |
IL139286A (en) * | 1998-04-28 | 2005-12-18 | Applied Research Systems | Polyol-ifn-beta conjugates, their preparation and use |
US6485972B1 (en) * | 1998-10-15 | 2002-11-26 | President And Fellows Of Harvard College | WNT signalling in reproductive organs |
BR9905867A (en) * | 1998-11-06 | 2001-01-23 | Bio Sidus S A | Recombinant human erythropoietin-producing cell line and the recombinant human erythropoietin produced by this cell |
US20030104561A1 (en) * | 1999-02-09 | 2003-06-05 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
WO2000061630A1 (en) * | 1999-04-08 | 2000-10-19 | President And Fellows Of Harvard College | Induction of kidney tubule formation |
US20020034772A1 (en) * | 1999-06-29 | 2002-03-21 | Orlow Seth J. | Methods and compositions that affect melanogenesis |
EP1248519A4 (en) * | 2000-01-18 | 2004-03-31 | Univ Leland Stanford Junior | Expansion of stem and progenitor cells by beta-catenin |
US6653448B1 (en) | 2000-03-29 | 2003-11-25 | Curagen Corporation | Wnt-7B-like polypeptides and nucleic acids encoding same |
US6600018B1 (en) * | 2000-04-10 | 2003-07-29 | The United States Of America As Represented By The Department Of Health And Human Services | Secreted frizzled related protein, sFRP, fragments and methods of use thereof |
AU2001273034A1 (en) * | 2000-06-26 | 2002-01-08 | Rxkinetix, Inc. | Composition for delivery of hematopoietic growth factor |
ATE282205T1 (en) | 2000-07-24 | 2004-11-15 | Health Research Inc | METHOD FOR DETECTING PROSTATE-SPECIFIC MEMBRANE ANTIGEN IN SERUM |
ES2522890T3 (en) | 2000-12-06 | 2014-11-19 | Anthrogenesis Corporation | Method to collect placental stem cells |
US7311905B2 (en) | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
EP1387854B1 (en) * | 2001-01-10 | 2012-03-21 | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Sfrp and peptide motifs that interact with sfrp and methods of their use |
IL157350A0 (en) | 2001-02-14 | 2004-02-19 | Anthrogenesis Corp | Post-partum mammalian placenta, its use and placental stem cells therefrom |
WO2002063962A1 (en) | 2001-02-14 | 2002-08-22 | Hariri Robert J | Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells |
US7087586B2 (en) * | 2001-04-24 | 2006-08-08 | Bioniche Life Sciences, Inc. | Oligonucleotide compositions and their use to induce differentiation of cells |
US20030044409A1 (en) * | 2001-05-01 | 2003-03-06 | Carson Dennis A. | Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens |
US7713526B2 (en) * | 2001-05-01 | 2010-05-11 | The Regents Of The University Of California | Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
AU2002308557A1 (en) * | 2001-05-01 | 2002-11-11 | The Regents Of The University Of California | Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
US7101693B2 (en) * | 2001-09-07 | 2006-09-05 | Brigham Young University | Plasticized hydrophilic glasses for improved stabilization of biological agents |
IL152904A0 (en) | 2002-01-24 | 2003-06-24 | Gamida Cell Ltd | Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations |
WO2003062404A1 (en) | 2002-01-25 | 2003-07-31 | Gamida-Cell Ltd. | Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby |
DE10209822A1 (en) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Coupling of low molecular weight substances to a modified polysaccharide |
DE10209821A1 (en) * | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Coupling of proteins to a modified polysaccharide |
WO2003076613A1 (en) * | 2002-03-11 | 2003-09-18 | Reprocell Inc. | Protein sustaining undifferentiated stem cells as such |
DE10212867B4 (en) * | 2002-03-22 | 2005-07-21 | Hans Prof. Dr. Wolf | Use of urea-adjuvated polypeptides for diagnosis, prophylaxis and therapy |
US7498171B2 (en) | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
AU2003241393A1 (en) * | 2002-05-09 | 2003-11-11 | New York University | Assay for melanogenesis |
JP2006513727A (en) | 2002-05-17 | 2006-04-27 | マウント シナイ スクール オブ メディスン オブ ニューヨーク ユニバーシティー | Mesodermal and adult endoderm cell populations |
CN1668733A (en) * | 2002-05-30 | 2005-09-14 | 细胞基因公司 | Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes |
EP1530418A4 (en) * | 2002-05-31 | 2005-10-12 | Univ Leland Stanford Junior | Methods of identifying and isolating stem cells and cancer stem cells |
CN100348618C (en) * | 2002-09-11 | 2007-11-14 | 弗雷泽纽斯卡比德国有限公司 | Process for producing hydroxyalkyl starch derivatives |
US20040247593A1 (en) * | 2002-10-04 | 2004-12-09 | Regents Of The University Of California, | Methods for treating cancer by inhibiting Wnt signaling |
US20060177932A1 (en) * | 2002-11-08 | 2006-08-10 | Hiromitsu Nakauchi | Expansion agents for stem cells |
WO2004047757A2 (en) * | 2002-11-21 | 2004-06-10 | University Of Massachusets | Diagnosing and treating hematopoietic cancers |
KR101042448B1 (en) | 2002-11-26 | 2011-06-16 | 안트로제네시스 코포레이션 | Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
CA2507581A1 (en) * | 2002-12-06 | 2004-06-24 | The Board Of Trustees Of The Leland Stanford Junior University | Protection of stem cells from cytotoxic agents by modulation of .beta.-catenin signaling pathways |
US7803783B2 (en) * | 2002-12-06 | 2010-09-28 | The Board Of Trustees Of The Leland Stanford Junior University | Use of WNT inhibitors to augment therapeutic index of chemotherapy |
CA2515552C (en) * | 2002-12-27 | 2012-09-18 | Mitsubishi Heavy Industries, Ltd. | Method and apparatus of cultivating multipotent stem cell |
WO2004091647A1 (en) | 2003-04-07 | 2004-10-28 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions of active wnt protein |
US20050043260A1 (en) * | 2003-04-21 | 2005-02-24 | Baylor College Of Medicine | Wnt as a factor for cardiac myogenesis |
AU2004249812B8 (en) * | 2003-06-25 | 2011-09-15 | Ottawa Hospital Research Institute | Methods and compositions for modulating stem cell growth and differentiation |
CN1812996A (en) * | 2003-06-25 | 2006-08-02 | 渥太华健康研究所 | Use of cardiotrophin to modulate stem cell proliferation |
US7939058B2 (en) * | 2003-07-03 | 2011-05-10 | University Of Southern California | Uses of IL-12 in hematopoiesis |
WO2005014655A2 (en) | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
WO2005092928A1 (en) | 2004-03-11 | 2005-10-06 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
ES2390885T3 (en) * | 2004-03-11 | 2012-11-19 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkylamidone and a protein |
CA2566498A1 (en) * | 2004-05-14 | 2005-12-08 | The Regents Of The University Of California | Methods for treating cancer using anti-wnt2 monoclonal antibodies and sirna |
EP1799812A4 (en) | 2004-09-16 | 2009-09-09 | Gamida Cell Ltd | Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells |
CN100572528C (en) * | 2004-09-28 | 2009-12-23 | 中国人民解放军军事医学科学院野战输血研究所 | A kind of method of amplification in vitro hematopoietic stem |
CA2827654C (en) | 2004-10-19 | 2019-04-02 | Regeneron Pharmaceuticals, Inc. | Method for generating an animal homozygous for a genetic modification |
US7850960B2 (en) * | 2004-12-30 | 2010-12-14 | University Of Washington | Methods for regulation of stem cells |
AU2012200875B2 (en) * | 2004-12-30 | 2012-08-30 | Robarts Research Institute | Methods for regulation of stem cells |
CA2598528A1 (en) * | 2005-03-11 | 2006-09-14 | Fresenius Kabi Deutschland Gmbh | Production of bioactive glycoproteins from inactive starting material |
WO2007030658A2 (en) * | 2005-09-08 | 2007-03-15 | Children's Hospital Medical Center | Compositions useful for and methods of modulating angiogenesis |
EP1762250A1 (en) * | 2005-09-12 | 2007-03-14 | Fresenius Kabi Deutschland GmbH | Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine |
EP1957633B1 (en) * | 2005-10-13 | 2013-12-18 | Anthrogenesis Corporation | Immunomodulation using placental stem cells |
US8846393B2 (en) | 2005-11-29 | 2014-09-30 | Gamida-Cell Ltd. | Methods of improving stem cell homing and engraftment |
KR20080081088A (en) | 2005-12-29 | 2008-09-05 | 안트로제네시스 코포레이션 | Co-culture of placental stem cells and stem cells from a second source |
CN103146640B (en) | 2005-12-29 | 2015-09-09 | 人类起源公司 | Placental stem cell populations |
CA2677679A1 (en) | 2007-02-12 | 2008-08-21 | Anthrogenesis Corporation | Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations |
NZ578819A (en) | 2007-02-12 | 2012-02-24 | Anthrogenesis Corp | Treatment of inflammatory diseases using placental stem cells |
US20080226707A1 (en) * | 2007-03-05 | 2008-09-18 | Jill Helms | WNT compositions and methods of use thereof |
EP2148569B1 (en) * | 2007-04-23 | 2014-07-16 | Stowers Institute for Medical Research | Methods and compositions for hematopoeitic stem cell self-renewal |
US9200253B1 (en) | 2007-08-06 | 2015-12-01 | Anthrogenesis Corporation | Method of producing erythrocytes |
ES2530995T3 (en) | 2007-09-28 | 2015-03-09 | Anthrogenesis Corp | Tumor suppression using human placental perfusate and intermediate natural killer cells that come from human placenta |
GB0803076D0 (en) | 2008-02-20 | 2008-03-26 | Univ Ghent | Mucosal Membrane Receptor and uses thereof |
MX339068B (en) | 2008-08-22 | 2016-05-10 | Anthrogenesis Corp | Methods and compositions for treatment of bone defects with placental cell populations. |
NZ602455A (en) | 2008-11-19 | 2014-03-28 | Anthrogenesis Corp | Amnion derived adherent cells |
US9121007B2 (en) | 2010-01-26 | 2015-09-01 | Anthrogenesis Corporatin | Treatment of bone-related cancers using placental stem cells |
KR20190076060A (en) | 2010-04-07 | 2019-07-01 | 안트로제네시스 코포레이션 | Angiogenesis using placental stem cells |
US8562973B2 (en) | 2010-04-08 | 2013-10-22 | Anthrogenesis Corporation | Treatment of sarcoidosis using placental stem cells |
JP6267510B2 (en) | 2010-05-18 | 2018-01-24 | ニューメディシンズ,インコーポレーテッド | IL-12 formulation for enhancing hematopoiesis |
EP2593542B1 (en) | 2010-07-13 | 2018-01-03 | Anthrogenesis Corporation | Methods of generating natural killer cells |
WO2012034070A1 (en) | 2010-09-09 | 2012-03-15 | The Board Of Trustees Of The Leland Stanford Junior University | Use of liposomal wnt compositions to enhance osseointegration |
AU2011352036A1 (en) | 2010-12-31 | 2013-07-18 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory RNA molecules |
US9040035B2 (en) | 2011-06-01 | 2015-05-26 | Anthrogenesis Corporation | Treatment of pain using placental stem cells |
US9925221B2 (en) | 2011-09-09 | 2018-03-27 | Celularity, Inc. | Treatment of amyotrophic lateral sclerosis using placental stem cells |
SG11201404608WA (en) | 2012-02-13 | 2014-09-26 | Gamida Cell Ltd | Mesenchymal stem cells conditioned medium and methods of generating and using the same |
US9567569B2 (en) | 2012-07-23 | 2017-02-14 | Gamida Cell Ltd. | Methods of culturing and expanding mesenchymal stem cells |
US9175266B2 (en) | 2012-07-23 | 2015-11-03 | Gamida Cell Ltd. | Enhancement of natural killer (NK) cell proliferation and activity |
US9763983B2 (en) | 2013-02-05 | 2017-09-19 | Anthrogenesis Corporation | Natural killer cells from placenta |
US20180360025A1 (en) * | 2015-07-22 | 2018-12-20 | Ramot At Tel-Aviv University Ltd. | Article of manufacture and methods for increasing survival of red blood cells |
SG11201906961UA (en) * | 2017-02-10 | 2019-08-27 | Genmab Bv | Polypeptide variants and uses thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994002157A1 (en) * | 1992-07-27 | 1994-02-03 | Indiana University Foundation | Human stem cell compositions and methods |
WO1995017416A1 (en) * | 1993-12-22 | 1995-06-29 | Merck & Co., Inc. | Dna encoding the wnt-x growth factor |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE266710C (en) * | ||||
US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US3691016A (en) * | 1970-04-17 | 1972-09-12 | Monsanto Co | Process for the preparation of insoluble enzymes |
CA1023287A (en) * | 1972-12-08 | 1977-12-27 | Boehringer Mannheim G.M.B.H. | Process for the preparation of carrier-bound proteins |
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US4002531A (en) * | 1976-01-22 | 1977-01-11 | Pierce Chemical Company | Modifying enzymes with polyethylene glycol and product produced thereby |
US4195128A (en) * | 1976-05-03 | 1980-03-25 | Bayer Aktiengesellschaft | Polymeric carrier bound ligands |
US4330440A (en) * | 1977-02-08 | 1982-05-18 | Development Finance Corporation Of New Zealand | Activated matrix and method of activation |
CA1093991A (en) * | 1977-02-17 | 1981-01-20 | Hideo Hirohara | Enzyme immobilization with pullulan gel |
USRE30985E (en) * | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
FR2413974A1 (en) * | 1978-01-06 | 1979-08-03 | David Bernard | DRYER FOR SCREEN-PRINTED SHEETS |
US4229537A (en) * | 1978-02-09 | 1980-10-21 | New York University | Preparation of trichloro-s-triazine activated supports for coupling ligands |
US4275149A (en) * | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
JPS6023084B2 (en) * | 1979-07-11 | 1985-06-05 | 味の素株式会社 | blood substitute |
US4399216A (en) * | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
ZA811368B (en) * | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
US4376110A (en) * | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
JPS6045849B2 (en) * | 1980-08-25 | 1985-10-12 | 林原 健 | Method for producing human erythropoietin |
US4419446A (en) * | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
US4485045A (en) * | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
NZ201705A (en) * | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
US4640835A (en) * | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
US4943529A (en) * | 1982-05-19 | 1990-07-24 | Gist-Brocades Nv | Kluyveromyces as a host strain |
US4601978A (en) * | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
US4560655A (en) * | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
US4657866A (en) * | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
US4713339A (en) * | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
AU2353384A (en) * | 1983-01-19 | 1984-07-26 | Genentech Inc. | Amplification in eukaryotic host cells |
US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4544545A (en) * | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
AU3145184A (en) * | 1983-08-16 | 1985-02-21 | Zymogenetics Inc. | High expression of foreign genes in schizosaccharomyces pombe |
US4767704A (en) * | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
US4496689A (en) * | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
US4965199A (en) * | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
US4879231A (en) * | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
DE3675588D1 (en) * | 1985-06-19 | 1990-12-20 | Ajinomoto Kk | HAEMOGLOBIN TIED TO A POLY (ALKENYLENE OXIDE). |
GB8516415D0 (en) * | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
US4676980A (en) * | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
AU597574B2 (en) * | 1986-03-07 | 1990-06-07 | Massachusetts Institute Of Technology | Method for enhancing glycoprotein stability |
US4927762A (en) * | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
GB8610600D0 (en) * | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
US4791192A (en) * | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
US4946783A (en) * | 1987-01-30 | 1990-08-07 | President And Fellows Of Harvard College | Periplasmic protease mutants of Escherichia coli |
US5010182A (en) * | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
IL87737A (en) * | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
GB8724885D0 (en) * | 1987-10-23 | 1987-11-25 | Binns M M | Fowlpox virus promotors |
EP0321196A3 (en) * | 1987-12-18 | 1990-07-18 | Mycogen Plant Science, Inc. | 780 t-dna gene transcription activator |
KR0154872B1 (en) * | 1987-12-21 | 1998-10-15 | 로버트 에이. 아미테이지 | Agrobacterium mediated transformation of germinating plant seeds |
AU4005289A (en) * | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
EP0435911B1 (en) * | 1988-09-23 | 1996-03-13 | Cetus Oncology Corporation | Cell culture medium for enhanced cell growth, culture longevity and product expression |
US5116964A (en) * | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
FR2646437B1 (en) * | 1989-04-28 | 1991-08-30 | Transgene Sa | NOVEL DNA SEQUENCES, THEIR APPLICATION AS A SEQUENCE ENCODING A SIGNAL PEPTIDE FOR THE SECRETION OF MATURE PROTEINS BY RECOMBINANT YEASTS, EXPRESSION CASSETTES, PROCESSED YEASTS AND PROCESS FOR PREPARING THE SAME |
DE394538T1 (en) * | 1989-04-28 | 1991-04-11 | Rhein Biotech Ges. Fuer Biotechnologische Prozesse Und Produkte Mbh, 4000 Duesseldorf, De | YEAR CELLS OF THE SCHWANNIOMYCES GENERATION. |
EP0402226A1 (en) * | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
EP0739904A1 (en) * | 1989-06-29 | 1996-10-30 | Medarex, Inc. | Bispecific reagents for aids therapy |
DK168302B1 (en) * | 1989-06-29 | 1994-03-07 | Danisco | Method of introducing molecules, especially genetic material into plant cells |
FR2649120B1 (en) * | 1989-06-30 | 1994-01-28 | Cayla | NOVEL STRAIN AND ITS MUTANTS OF FILAMENTOUS MUSHROOMS, PROCESS FOR PRODUCING RECOMBINANT PROTEINS USING SAID STRAIN, AND STRAINS AND PROTEINS OBTAINED BY SAID METHOD |
US5013556A (en) * | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
EP0502036B1 (en) * | 1989-11-22 | 1995-12-20 | Genentech, Inc. | Latency associated peptide and uses therefor |
US5122469A (en) * | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
US5206161A (en) * | 1991-02-01 | 1993-04-27 | Genentech, Inc. | Human plasma carboxypeptidase B |
WO1992020373A1 (en) * | 1991-05-14 | 1992-11-26 | Repligen Corporation | Heteroconjugate antibodies for treatment of hiv infection |
WO1993008829A1 (en) * | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
CA2140280A1 (en) * | 1992-08-17 | 1994-03-03 | Avi J. Ashkenazi | Bispecific immunoadhesins |
SE470423B (en) * | 1992-12-18 | 1994-02-21 | Sp Wm Dricksvatten Ab | Apparatus for separating emulsions by electrochemical precipitation |
US5635388A (en) * | 1994-04-04 | 1997-06-03 | Genentech, Inc. | Agonist antibodies against the flk2/flt3 receptor and uses thereof |
-
1996
- 1996-08-16 US US08/696,566 patent/US5851984A/en not_active Expired - Lifetime
-
1997
- 1997-08-07 EP EP97936448A patent/EP0918794B1/en not_active Expired - Lifetime
- 1997-08-07 IL IL12812997A patent/IL128129A0/en active IP Right Grant
- 1997-08-07 AU AU39112/97A patent/AU721947B2/en not_active Expired
- 1997-08-07 AT AT97936448T patent/ATE252113T1/en not_active IP Right Cessation
- 1997-08-07 DE DE69725587T patent/DE69725587T2/en not_active Expired - Lifetime
- 1997-08-07 WO PCT/US1997/013910 patent/WO1998006747A2/en active IP Right Grant
- 1997-08-07 ES ES97936448T patent/ES2208943T3/en not_active Expired - Lifetime
- 1997-08-07 JP JP50986198A patent/JP3759623B2/en not_active Expired - Lifetime
-
1999
- 1999-01-19 IL IL128129A patent/IL128129A/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994002157A1 (en) * | 1992-07-27 | 1994-02-03 | Indiana University Foundation | Human stem cell compositions and methods |
WO1995017416A1 (en) * | 1993-12-22 | 1995-06-29 | Merck & Co., Inc. | Dna encoding the wnt-x growth factor |
Non-Patent Citations (2)
Title |
---|
D. J. VAN DEN BERG ET AL.: "A ROLE FOR THE MEMBERS OF THE WNT GENE FAMILY IN HUMAN HEMATOPOIESIS.", BLOOD, vol. 88, no. 10, 15 November 1996 (1996-11-15), pages 141A, XP002058233 * |
TIMOTHY W. AUSTIN ET AL.: "A ROLE FOR THE WNT GENE FAMILY IN HEMATOPOIESIS:EXPANSION OF MULTILINEAGE PROGENITOR CELLS.", BLOOD, vol. 89, no. 10, 15 May 1997 (1997-05-15), pages 3624 - 3635, XP002058232 * |
Also Published As
Publication number | Publication date |
---|---|
AU721947B2 (en) | 2000-07-20 |
WO1998006747A2 (en) | 1998-02-19 |
JP3759623B2 (en) | 2006-03-29 |
EP0918794B1 (en) | 2003-10-15 |
ATE252113T1 (en) | 2003-11-15 |
DE69725587T2 (en) | 2004-07-29 |
IL128129A0 (en) | 1999-11-30 |
US5851984A (en) | 1998-12-22 |
EP0918794A2 (en) | 1999-06-02 |
DE69725587D1 (en) | 2003-11-20 |
JP2000516466A (en) | 2000-12-12 |
ES2208943T3 (en) | 2004-06-16 |
AU3911297A (en) | 1998-03-06 |
IL128129A (en) | 2006-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998006747A3 (en) | Uses for wnt polypeptides | |
CA2198603A1 (en) | Use of Stem Cell Factor and Soluble Interleukin-6 Receptor for the Ex Vivo Expansion of Hematopoietic Multipotential Cells | |
AU1750297A (en) | Humanized green fluorescent protein genes and methods | |
HK1091228A1 (en) | Methods for making recombinant proteins using apoptosis inhibitors | |
WO2000053761A3 (en) | Human cytokine as ligand of the zalpha receptor and uses thereof | |
IL142094A0 (en) | Methods of controlling proliferation and differentiation of stem and progenitor cells | |
GR3035019T3 (en) | Interleukin-15 | |
IL135068A0 (en) | Stimulation of hematopoietic cells in vitro | |
EP1398370A3 (en) | In-vitro micro-organs | |
AU9582398A (en) | Methods and devices for the long-term culture of hematopoietic progenitor cells | |
WO2001000788A3 (en) | Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells | |
IL148008A0 (en) | Conditional immortalisation of cells | |
IL132496A0 (en) | Mammalian cytokine-like factor 7 | |
AU3392697A (en) | (in vitro) derivation and culture of primate pluripotent stem cells and therapeutic uses thereof | |
AU1706399A (en) | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation | |
DE69526395D1 (en) | Use of interferon-gamma to avoid proliferation and differentiation of the primitive hematopoietic progenitor cells | |
ATE225806T1 (en) | D-2-ALKYLTRYPTOPHANE CONTAINING POLYPEPTIDES WITH GROWTH HORMONE RELEASING ACTIVITY | |
AU2002304249A1 (en) | Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same | |
YU41798A (en) | Scf analogous compositions and methods | |
NZ503401A (en) | Use of interferon-beta (IFN-B) genes for the treatment of cancer | |
CA2262469A1 (en) | Uses for wnt polypeptides | |
HU9600432D0 (en) | Novel tripeptides useful in immune and cns therapy | |
MXPA04001526A (en) | Kgf polypeptide compositions. | |
AU2000256229A1 (en) | Production of secreted polypeptides | |
AU133755S (en) | Hand trolley |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1997936448 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2262469 Country of ref document: CA Ref country code: CA Ref document number: 2262469 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1998 509861 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 1997936448 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 1997936448 Country of ref document: EP |